ID   OV177
AC   CVCL_A403
SY   Ov177; ov177; OV 177
DR   Cosmic; 845144
DR   Cosmic; 1523767
DR   GEO; GSM659386
DR   Wikidata; Q54936882
RX   PubMed=9473353;
RX   PubMed=9625810;
RX   PubMed=30485824;
CC   Omics: Genome sequenced.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): PubMed=30485824
ST   Amelogenin: X
ST   CSF1PO: 10,15
ST   D13S317: 12
ST   D16S539: 13
ST   D21S11: 28
ST   D5S818: 11
ST   D7S820: 9,11
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
RX   PubMed=9473353; DOI=10.1006/excr.1997.3861;
RA   Conover C.A., Hartmann L.C., Bradley S.V., Stalboerger P.G., Klee G.G.,
RA   Kalli K.R., Jenkins R.B.;
RT   "Biological characterization of human epithelial ovarian carcinoma
RT   cells in primary culture: the insulin-like growth factor system.";
RL   Exp. Cell Res. 238:439-449(1998).
//
RX   PubMed=9625810; DOI=10.3892/ijo.13.1.101;
RA   Yokomizo A., Tindall D.J., Hartmann L.C., Jenkins R.B., Smith D.I.,
RA   Liu W.-G.;
RT   "Mutation analysis of the putative tumor suppressor PTEN/MMAC1 in
RT   human ovarian cancer.";
RL   Int. J. Oncol. 13:101-105(1998).
//
RX   PubMed=30485824; DOI=10.1016/j.celrep.2018.10.096; PMCID=PMC6481945;
RA   Papp E., Hallberg D., Konecny G.E., Bruhm D.C., Adleff V., Noe M.,
RA   Kagiampakis I., Palsgrove D., Conklin D., Kinose Y., White J.R.,
RA   Press M.F., Drapkin R.I., Easwaran H., Baylin S.B., Slamon D.J.,
RA   Velculescu V.E., Scharpf R.B.;
RT   "Integrated genomic, epigenomic, and expression analyses of ovarian
RT   cancer cell lines.";
RL   Cell Rep. 25:2617-2633(2018).
//